Novel Portable Diagnostic Device for Automatic Detection of Relative A
New Automatic Portable Ophthalmology Device
What it found
Results are posted in the registry, but without a statistical test of the main measure. See the numbers below.
What was tested
Treatment tested
- O-Glass
Compared with
- Swinging Flashlight Test
Results by group
Number of Participants With Detected Relative Afferent Pupillary Defect (RAPD)
up to 6 months
| Group | Value | Interval | Number analysed |
|---|---|---|---|
| O-Glass | 44 participants | 44 | |
| Swinging Flashlight Test | 37 participants | 44 |
O-Glass
Swinging Flashlight Test
Values as posted on ClinicalTrials.gov. Outcomes measured differently across trials are not directly comparable.
Safety
| Group | Participants at risk | Serious adverse events | Deaths |
|---|---|---|---|
| All Study Participants | 44 | 0 (0.0%) |
As posted on ClinicalTrials.gov. Serious adverse events include any serious health event during the trial, whether or not the treatment caused it.
What it measured
Main measures
Number of Participants With Detected Relative Afferent Pupillary Defect (RAPD)
up to 6 months
Who could take part
MS (type not specified) · 20 to 55
Show the full criteria
Inclusion criteria
* positive relative afferent pupillary defect
Exclusion criteria
-
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
This study is to evaluate the ability of a newly designed device, Optic Nerve Glass (O-Glass) to detect relative afferent pupillary defect (RAPD). In this prospective study, 44 patients (diagnosed RAPD- positive) enrolled the study. They were examined for an RAPD by O-Glass and also manual swinging flashlight method (SFM) . This newly designed instrument captures and records eye pictures. The images will be processed and analyzed using computerized software to calculate pupillary measurements.
Loading reviews and guidelines…
History
Started
Dec 2015
Main results due
May 2016
Finished
Jun 2016
Results posted
Nov 2016